Company / Cost of Revenue
BioLife Solutions, Inc. Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$34.1M
FY2025
5-year range
$24.6M / $34.1M
FY2021-FY2025
Trend
+38.9%
vs FY2024
Sector context
#102 of 107
Health Care
What the data says
Among 107 Health Care companies, BioLife Solutions, Inc. is in the top 5% for cost of revenue. Cost of Revenue has fluctuated over the past 7 years, ranging from $2M in FY2019 to $34M in FY2025.
Based on SEC 10-K filings.
$34M in FY2025.
Increased from $27M to $34M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 107This company $34.1M Sector average $11.8B
▼
-99.7% below sector average
Key checks
Key Insights
- In FY2025, cost of revenue increased 38.9% year-over-year.
- Ranks #102 out of 107 companies in the Health Care sector.
- Lowest cost of revenue in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $34.1M | +38.9% |
| FY2024 | $24.6M | -8.0% |
| FY2023 | $26.7M | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $1.6M | -43.2% |
| FY2018 | $2.9M | -32.2% |
| FY2017 | $4.3M | +24.0% |
| FY2016 | $3.4M | +30.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026